TLRY stock jumped 65% this week, marking its best weekly performance in company history. The explosive rally stems from two major catalysts: the successful completion of a 1-for-10 reverse stock split and mounting optimism around federal marijuana reclassification under the Trump administration.
🔥 Quick Facts
- TLRY surged 65% during the week ending December 14, 2025, its best weekly gain ever
- The 1-for-10 reverse stock split became effective on December 1, 2025, reducing the float to approximately 116 million shares
- Tilray regained NASDAQ compliance by meeting the $1.00 minimum bid price requirement for the NASDAQ Global Select Market
- Stock climbed to $13.53 by December 15th, with trading volume exceeding 80 million shares on December 12th alone
The Reverse Stock Split: Why It Matters
Intuit emerges as best software stock for 2026 while stock crashes to bargain levels analysts didn’t expect
2026 tax brackets shock Americans with hidden paycheck truth nobody expected
Tilray’s reverse stock split wasn’t just about hitting a price target. The 1-for-10 consolidation reduced the company’s share count significantly, making each remaining share worth substantially more in absolute terms.
This move addressed long-standing NASDAQ listing concerns. For months, Tilray faced pressure to maintain its exchange listing as shares traded dangerously close to the minimum $1.00 bid price. The reverse split eliminated this existential threat while also improving institutional accessibility, since many larger funds have policies against owning penny stocks.
| Metric | Details |
| Reverse Split Ratio | 1-for-10 |
| Effective Date | December 1, 2025 |
| New Float | Approximately 116 million shares |
| Current Stock Price (Dec 15) | $13.53 |
| Weekly Performance | +65% |
Cannabis Reclassification: The Real Driver
Marcus Lemonis takes CEO role at Bed Bath & Beyond with $25M cost-cutting plan and watch what industry experts are saying about his next move
SPX surges 34 points at open with shocking tech recovery, here’s what caused the unexpected Venezuela rally
While the reverse split was necessary, the spectacular 65% surge this week came from a different source: reports that the Trump administration plans to reclassify marijuana to Schedule III status.
Unlike the current Schedule I classification (which puts cannabis alongside substances like heroin), Schedule III designation would acknowledge potential medical applications while maintaining federal restrictions. This reclassification could dramatically improve the investment case for companies like Tilray by easing tax burdens and potentially unlocking banking relationships.
“President Trump is expected to direct his cabinet to move forward on a proposal to reclassify cannabis to Schedule III.”
— Cannabis Business Times, December 12, 2025
Why This Matters for Institutional Investors
The combination of restored NASDAQ compliance and potential federal policy changes creates a unique inflection point. Large institutional funds that have avoided cannabis stocks due to listing concerns or regulatory uncertainty may now reconsider their positions.
Tilray’s reverse split achieved multiple objectives simultaneously. It satisfied NASDAQ’s minimum price requirement, reduced share count volatility, and positioned the company to benefit from favorable policy developments. The stock’s ability to trade near $13.53 post-split demonstrates that the consolidation succeeded in projecting a healthier corporate profile.
What Investors Should Watch Going Forward
The 65% weekly surge represents exceptional momentum, but the sustainability of these gains depends on concrete policy action. While Trump administration officials have signaled openness to Schedule III reclassification, no final decisions have been officially announced.
Additional factors to monitor include quarterly earnings reports, competitive positioning within the cannabis and beverage sectors, and the timeline for potential federal rescheduling legislation. The reverse split removes immediate delisting concerns, but long-term shareholder value depends on business fundamentals and regulatory tailwinds developing as expected.
Can TLRY Stock Maintain This Momentum Throughout December?
The next critical catalysts for TLRY stock will likely emerge from formal policy announcements rather than technical factors. The reverse split was completed successfully, and NASDAQ compliance is restored, so those headline risks are effectively resolved.
What remains uncertain is whether the 65% weekly gain marks a new baseline or represents a temporary sentiment spike. Cannabis investors have experienced multiple rounds of regulatory optimism followed by disappointment. True sustainability would require official federal action on reclassification, banking reform, and industry legitimacy—developments that could take weeks or months to materialize.
Sources
- NASDAQ – Official press releases on Tilray reverse split implementation
- Reuters – Cannabis stocks surge on Trump administration marijuana reclassification signals
- Washington Post – Trump seeks to cut restrictions on marijuana through reclassification
Patrick Graham is a business and finance journalist translating Wall Street’s complexities into stories that matter to everyday readers. With extensive experience in financial journalism and economic analysis, this expert journalist provides sharp insights on market trends, corporate developments, and the economic forces affecting daily life. His reporting helps readers make sense of the business world’s biggest moves.